Get the Daily Brief
Latest Biotech News
FDA Takes Closer Look at Surrogate Endpoints Under CDER Director Tidmarsh
George Tidmarsh, director of the FDA's Center for Drug Evaluation and Research (CDER), signaled a review of the agency's use of surrogate endpoints for drug approval. These endpoints, which rely...
Revolutionary AI-Based Stool Test Achieves 90% Accuracy for Early Colorectal Cancer Detection
Researchers at the University of Geneva developed an AI-powered stool test that offers non-invasive, early detection of colorectal cancer with approximately 90% accuracy. This screening tool could...
Breakthrough Study Reveals How Polymyxin B Destroys Bacterial Defenses
New research from University College London and Imperial College London elucidates how Polymyxin B, a last-resort antibiotic, kills Gram-negative bacteria by triggering active disruption and...
First-in-Human Trial of IL-12 Drug tolododekin Alfa Shows Promise in Solid Tumors
Clinical trial results for tolododekin alfa, an interleukin-12 (IL-12) anchored drug conjugate, reveal successful harnessing of IL-12’s immunomodulatory effects with reduced systemic toxicity. The...
Liposomal Iron Shows Major Improvement in Pediatric CKD Anemia Management
A randomized clinical trial highlights the efficacy of liposomal iron therapy in treating iron deficiency anemia among pediatric chronic kidney disease (CKD) patients. The treatment significantly...
Groundbreaking AI Model Differentiates Glioblastoma from Similar Brain Tumors in Real Time
A team from Harvard Medical School unveiled an AI tool capable of accurately distinguishing glioblastoma from other visually similar brain tumors intraoperatively. This real-time diagnostic...
Revolutionary mRNA Vaccine Halts Retinal Neovascularization in Age-Related Macular Degeneration Models
Researchers at the Institute of Science Tokyo developed an mRNA vaccine that suppresses pathological blood vessel growth in mouse models of age-related macular degeneration (AMD). Delivered...
Novel Analytical Tool COOKIE-Pro Advances Covalent Inhibitor Drug Optimization
Baylor College of Medicine scientists introduced COOKIE-Pro, a cutting-edge analytical platform that delivers unprecedented insight into covalent inhibitor interactions with the proteome. By...
Genmab Names In-House CEOs as GSK and Merck KGaA Also Appoint Internal Leaders
Genmab, GSK, and Merck KGaA have all appointed new chief executives sourced internally, reflecting a trend toward continuity and leveraging internal expertise within leading biopharma firms. This...
Genmab's $8B Purchase of Merus Secures Head and Neck Cancer Candidate
Danish biopharma Genmab has agreed to acquire Dutch company Merus for $8 billion in cash, gaining full rights to Merus's late-stage bispecific antibody petosemtamab, targeted for head and neck...
FDA Reevaluates Drug Approval Processes and Regulatory Strategies
The FDA is scrutinizing its use of surrogate endpoints for expedited drug approvals, with CDER director George Tidmarsh indicating a 'close look' at these criteria to ensure clinical benefit....
Advances in Artificial Intelligence Revolutionize Biotech Research and Diagnostics
Artificial intelligence continues to transform biotechnology with several new innovations: Harvard Medical School researchers have developed an AI tool for real-time distinction between...
Promising Clinical Radiation Therapy Advances Across Multiple Cancer Types
Recent clinical trials demonstrate the efficacy and quality-of-life benefits of radiation therapies in cancer treatment. A decade-long study found stereotactic radiation matches surgery for...
Pioneering Immunotherapies and Cancer Research Reveal New Therapeutic Avenues
Breakthroughs in cancer immunotherapy show promise in addressing aggressive and treatment-resistant tumors. Researchers unveiled a biodegradable scaffold delivering TLR7/8 agonists that eradicated...
Major Funding and Investment Moves Signal Strategic Biotech Growth
Sanofi reinforced its commitment to biotechnology innovation with a $625 million capital boost to Sanofi Ventures, expanding total assets over $1.4 billion. The venture fund aims to back...
Innovations in Antibiotic Mechanisms Illuminate Bacterial Resistance Challenges
New research using high-resolution imaging reveals how polymyxin B, a last-resort antibiotic, kills bacteria by inducing energy-dependent disruption of the bacterial outer membrane. The study...
Cutting-Edge mRNA Vaccines Target Chronic and Infectious Diseases
Researchers have developed innovative mRNA vaccines expanding beyond infectious diseases. A novel intramuscular mRNA vaccine delivering LRG1 protein mRNA inhibited pathological neovascularization...
Healthcare Leadership Transitions and Market Responses in Pharma Sector
GlaxoSmithKline (GSK) announced CEO Emma Walmsley's departure effective December 31, transitioning leadership to Chief Commercial Officer Luke Miels on January 1. Walmsley’s nine-year tenure...
Breakthrough Single-Cell and Spatial Transcriptomics Tools Enhance Disease Research
Scientists at the University of California developed ClearSeqExtend, an advanced computational platform improving single-cell RNA sequencing analysis by correcting ambient RNA contamination and...
Genmab Acquires Merus for $8 Billion Boost in Head and Neck Cancer Drug
Genmab has announced an $8 billion all-cash acquisition of Dutch biotech Merus, securing full rights to Merus's late-stage bispecific antibody, petosemtamab, currently in pivotal trials for head...